The U.S. Court of Appeals for the Federal Circuit ruled in favor of Watson Pharmaceuticals during patent litigation concerning the drug maker's abbreviated new drug application for an overactive bladder treatment.

Watson is challenging the patent protection on two eye drugs made by Allergan, the generic drug maker said Tuesday.

Allergan reappointed David Pyott as president earlier this week, adding to his role as chairman and CEO. Pyott will succeed Michael Ball, who has accepted the position of CEO at Hospira, a specialty pharmaceutical and medication delivery company, Allergan reported.

Valeant Pharmaceuticals subsidiary Biovail Labs International has licensed Canadian rights to a treatment for acne from Allergan, Valeant said Tuesday.

Anticipating regulatory approval, MAP Pharmaceuticals and Allergan will collaborate to promote a drug for treating acute migraine to physicians.

The president and CEO of Agensys, a subsidiary of Japanese drug maker Astellas, will retire,...

Greenstone announced the launch of an authorized generic version of the Alzheimer’s disease drug Aricept...

Allergan's optimized reformulation of Lumigan has received approval from the Food and Drug Administration, the...

Bristol-Myers Squibb is buying most of the rights to an investigational pain drug for $40...